https://www.selleckchem.com/products/PLX-4720.html
8 ± 4.3 vs 8.4 ± 6.8 days; P .01). There was no difference in time to reimplantation, change in ROM from pre-Stage 1 to most recent follow-up, or reinfection. Real-component spacers had shorter hospital stays (3.3 ± 1.7 vs 5.4 ± 4.9 days; P .01) and operative times during Stage 2 (162.2 ± 47.5 vs 188.0 ± 66.0minutes; P= .01). Real-component spacers had improved ROM after Stage 1 and lower blood loss, shorter operative time, and shorter hospital stays after Stage 2 compared to all-cement articulating spacers. The 2 spacer cons
Like
Comment
Share
